Invention Grant
- Patent Title: Substituted quinolines useful as kinase inhibitors
-
Application No.: US16970349Application Date: 2019-02-20
-
Publication No.: US11427559B2Publication Date: 2022-08-30
- Inventor: Dawei Zhang
- Applicant: Dawei Zhang
- Applicant Address: US CA Thousand Oaks
- Assignee: Dawei Zhang
- Current Assignee: Dawei Zhang
- Current Assignee Address: US CA Thousand Oaks
- Agent Feng Tian
- International Application: PCT/US2019/018841 WO 20190220
- International Announcement: WO2019/165003 WO 20190829
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61P35/00
Abstract:
The present invention is directed to novel quinoline-3-carbonitriles according to Formula I, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities and are useful for the treatment of protein kinases mediated diseases and conditions.
Public/Granted literature
- US20210087166A1 SUBSTITUTED QUINOLINES USEFUL AS KINASE INHIBITORS Public/Granted day:2021-03-25
Information query
